The following information should be read in conjunction with the condensed
consolidated financial statements, including the notes thereto, included
elsewhere in this Form 10-Q and Management's Discussion and Analysis of
Financial Condition and Results of Operations included in our Annual Report on
Form 10-K for the year ended December 31, 2020.
FARO Technologies, Inc. ("FARO," the "Company," "us," "we" or "our") has made
"forward-looking statements" in this report (within the meaning of the Private
Securities Litigation Reform Act of 1995). Statements that are not historical
facts or that describe our plans, beliefs, goals, intentions, objectives,
projections, expectations, assumptions, strategies, or future events are
forward-looking statements. In addition, words such as "may," "might," "would,"
"will," "will be," "future," "strategy," "believe," "plan," "should," "could,"
"seek," "expect," "anticipate," "intend," "estimate," "goal," "objective,"
"project," "forecast," "target" and similar words identify forward-looking
statements.
Forward-looking statements are not guarantees of future performance and are
subject to a number of known and unknown risks, uncertainties, and other factors
that could cause actual results to differ materially from those expressed or
implied by such forward-looking statements. Consequently, undue reliance should
not be placed on these forward-looking statements. We do not intend to update
any forward-looking statements, whether as a result of new information, future
events, or otherwise, unless otherwise required by law. Important factors that
could cause actual results to differ materially from those contemplated in such
forward-looking statements include, among others, the following:

•an economic downturn in the manufacturing industry or the domestic and
international economies in the regions of the world where we operate;
•the effect of the COVID-19 pandemic, including on our business operations, as
well as its impact on general economic and financial market conditions;
•our inability to realize the intended benefits of our undertaking to transition
to a company that is reorganized around functions to improve the efficiency of
our sales organization and to improve operational effectiveness;
•our inability to successfully execute our new strategic plan and restructuring
plan, including but not limited to additional impairment charges and/or higher
than expected severance costs and exist costs, and our inability to realize the
expected benefits of such plans;
•our inability to further penetrate our customer base and target markets;
•development by others of new or improved products, processes or technologies
that make our products less competitive or obsolete;
•our inability to maintain what we believe to be our technological advantage by
developing new products and enhancing our existing products;
•loss of future government sales; and potential impacts on customer and supplier
relationships and on the Company's reputation that may result from the GSA
matter;
•risks associated with expanding international operations, such as difficulties
in staffing and managing foreign operations, increased political and economic
instability, compliance with potentially evolving import and export regulations,
and the burdens and potential exposure of complying with a wide variety of U.S.
and foreign laws and labor practices;
•changes in trade regulation, which result in rising prices of imported steel,
steel byproducts, aluminum and aluminum byproducts and various other raw
materials that we use in the production of measurement devices, and our ability
to pass those costs on to our customers or require our suppliers to absorb such
costs;
•changes in foreign regulation which may result in rising prices of our
measurement devices sold as exports to our international customers, our
customers' willingness to absorb incremental import tariffs, and the
corresponding impact on our profitability;
•our inability to successfully identify and acquire target companies and achieve
expected benefits from, and effectively integrate, acquisitions that are
consummated;
•the cyclical nature of the industries of our customers and material adverse
changes in our customers' access to liquidity and capital;
•changes in the potential for the computer-aided measurement market and the
potential adoption rate for our products, which are difficult to quantify and
predict;
•our inability to protect our patents and other proprietary rights in the United
States and foreign countries;
                                       20
--------------------------------------------------------------------------------
  Table of Contents
•our inability to adequately establish and maintain effective internal controls
over financial reporting;
•fluctuations in our annual and quarterly operating results and the inability to
achieve our financial operating targets as a result of a number of factors
including, without limitation (i) litigation and regulatory action brought
against us, (ii) quality issues with our products, (iii) excess or obsolete
inventory, shrinkage or other inventory losses due to product obsolescence,
change in demand for our products, scrap or material price changes, (iv) raw
material price fluctuations and other inflationary pressures, (v) expansion of
our manufacturing capability, (vi) the size and timing of customer orders,
(vii) the amount of time that it takes to fulfill orders and ship our products,
(viii) the length of our sales cycle to new customers and the time and expense
incurred in further penetrating our existing customer base, (ix) manufacturing
inefficiencies associated with new product introductions, (x) costs associated
with new product introductions, such as product development, marketing, assembly
line start-up costs and low introductory period production volumes, (xi) the
timing and market acceptance of new products and product enhancements,
(xii) customer order deferrals in anticipation of new products and product
enhancements, (xiii) the inability of our sales and marketing programs to
achieve their sales targets, (xiv) start-up costs associated with opening new
sales offices outside of the United States, (xv) fluctuations in revenue without
proportionate adjustments in fixed costs, (xvi) inefficiencies in the management
of our inventories and fixed assets, (xvii) compliance with government
regulations including health, safety, and environmental matters, and (xviii)
costs associated with the training and ramp-up time for new sales people;
•changes in gross margins due to a changing mix of products sold and the
different gross margins on different products and sales channels;
•changes in applicable laws, rules or regulations, or their interpretation or
enforcement, or the enactment of new laws, rules or regulations that apply to
our business operations or require us to incur significant expenses for
compliance;
•our inability to successfully comply with the requirements of the Restriction
of Hazardous Substances Directive and the Waste Electrical and Electronic
Equipment Directive in the European Union;
•the inability of our products to displace traditional measurement devices and
attain broad market acceptance;
•the impact of competitive products and pricing on our current offerings;
•our ability to successfully complete our executive officer transitions and the
loss of any of our executive officers or other key personnel;
•difficulties in recruiting research and development engineers and application
engineers;
•the failure to effectively manage the effects of any future growth;
•the impact of reductions or projected reductions in government spending, or
uncertainty regarding future levels of government expenditures, particularly in
the defense sector;
•variations in our effective income tax rate, which makes it difficult to
predict our effective income tax rate on a quarterly and annual basis, and the
impact of the U.S. Tax Cuts and Jobs Act of 2017 on the global intangible
low-taxed income of foreign subsidiaries;
•the loss of key suppliers and the inability to find sufficient alternative
suppliers in a reasonable period of time or on commercially reasonable terms;
•the impact of fluctuations in exchange rates;
•the effect of estimates and assumptions with respect to critical accounting
policies and the impact of the adoption of recently issued accounting
pronouncements;
•the magnitude of increased warranty costs from new product introductions and
enhancements to existing products;
•the sufficiency of our plants to meet manufacturing requirements;
•the continuation of our share repurchase program;
•the sufficiency of our working capital and cash flow from operations to fund
our long-term liquidity requirements;
•the impact of geographic changes in the manufacturing or sales of our products
on our effective income tax rate;
•our ability to comply with the requirements for favorable tax rates in foreign
jurisdictions; and
•other risks and uncertainties discussed in Part I, Item 1A. Risk Factors in our
Annual Report on Form 10-K for the year ended December 31, 2020 and in other SEC
filings.
                                       21
--------------------------------------------------------------------------------
  Table of Contents
Moreover, new risks and uncertainties emerge from time to time, and we undertake
no obligation to update publicly or review the risks and uncertainties included
in this Quarterly Report on Form 10-Q, unless otherwise required by law.
Overview
We are a global technology company that designs, develops, manufactures, markets
and supports software driven, three-dimensional ("3D") measurement, imaging, and
realization solutions for the 3D metrology, architecture, engineering and
construction ("AEC") and public safety analytics markets. We enable our
customers to capture, measure, manipulate, interact with and share data from the
physical world in a virtual environment and then translate this information back
into the physical domain. Our technology enables highly accurate 3D measurement,
imaging, comparison and projection of parts and complex structures within
production, assembly and quality assurance processes. Our FARO suite of 3D
products and software solutions are used for inspection of components and
assemblies, rapid prototyping, reverse engineering, documenting large volume or
structures in 3D, surveying and construction, assembly layout, machine guidance
as well as in investigation and reconstructions of crash and crime scenes. We
sell the majority of our solutions through a direct sales force across a range
of industries including automotive, aerospace, metal and machine fabrication,
surveying, architecture, engineering and construction, public safety forensics
and other industries.
We derive our revenues primarily from the sale of our measurement equipment and
related multi-faceted software programs. Revenue related to these products is
generally recognized upon shipment. In addition, we sell extended warranties and
training and technology consulting services relating to our products. We
recognize the revenue from hardware service contracts and software maintenance
contracts on a straight-line basis over the contractual term, and revenue from
training and technology consulting services when the services are provided.
We operate in international markets throughout the world and maintain sales
offices in Australia, Brazil, Canada, China, France, Germany, India, Italy,
Japan, Malaysia, Mexico, the Netherlands, Poland, Portugal, Singapore, South
Korea, Spain, Switzerland, Thailand, Turkey, the United Kingdom, and the United
States.
We manufacture our FARO Quantum Arm products in our manufacturing facility
located in Switzerland for customer orders from Europe, the Middle East and
Africa ("EMEA"), in our manufacturing facility located in Singapore for customer
orders from the Asia-Pacific region, and in our manufacturing facility located
in Florida for customer orders from the Americas. We manufacture our FARO
Focus laser scanner in our manufacturing facilities located in Germany and
Switzerland for customer orders from EMEA and the Asia-Pacific region, and in
our manufacturing facility located in Pennsylvania for customer orders from the
Americas. We manufacture our FARO Laser Tracker and our FARO Laser Projector
products in our facility located in Pennsylvania. We expect all of our existing
manufacturing facilities to have the production capacity necessary to support
our volume requirements during 2021.
We account for wholly-owned foreign subsidiaries in the currency of the
respective foreign jurisdiction; therefore, fluctuations in exchange rates may
have an impact on the value of the intercompany account balances denominated in
different currencies and reflected in our consolidated financial statements. We
are aware of the availability of off-balance sheet financial instruments to
hedge exposure to foreign currency exchange rates, including cross-currency
swaps, forward contracts and foreign currency options. However, we have not used
such instruments in the past, and none were utilized in 2020 or the three months
ended March 31, 2021.
New Strategic Plan and Restructuring Plan
In the first quarter of 2020, our Board of Directors approved a global
restructuring plan (the "Restructuring Plan"), which is intended to support our
strategic plan in an effort to improve operating performance and ensure that we
are appropriately structured and resourced to deliver increased and sustainable
value to our shareholders and customers. Key activities under the Restructuring
Plan include a continued focus on efficiency and cost-saving efforts, which
includes decreasing total headcount by approximately 500 employees upon the
completion of the Restructuring Plan.
These activities are expected to be substantially completed by the end of 2021.
Pre-tax charges of approximately $49 million recorded in the fourth quarter of
2019 in connection with the implementation of our new strategic plan and
included the following:
•$21.2 million impairment of goodwill;
•$12.8 million charge, increasing our reserve for excess and obsolete inventory;
•$10.5 million impairment of intangible assets associated with recent
acquisitions;
•$1.4 million impairment of intangible assets related to capitalized patents;
•$3.4 million impairment of other assets and other charges.
                                       22
--------------------------------------------------------------------------------
  Table of Contents
In connection with the Restructuring Plan, we recorded a pre-tax charge of
approximately $15.8 million during the year ended December 31, 2020 primarily
consisting of severance and related benefits, professional fees and other
related charges and costs including a non-cash expense of $0.4 million related
to the disposal of our Photonics business and 3D Design related assets. We
received $0.7 million in cash payments for the disposal of our Photonics
business and 3D Design related assets in the second quarter of 2020. Currently,
we have several significant cost reduction initiatives underway to achieve our
20% target EBITDA margins that could result in pre-tax charges in the range of
$5 million to $15 million for fiscal year 2021.
At this time, we are continuing to evaluate the future key activities by which
these additional charges will originate. Actual results, including the costs of
the Restructuring Plan, may differ materially from our expectations, resulting
in our inability to realize the expected benefits of the Restructuring Plan and
our new strategic plan and negatively impacting our ability to execute our
future plans and strategies, which could have a material adverse effect on our
business, financial condition and results of operations.
In connection with the Restructuring Plan, we paid $13.1 million during the year
ended December 31, 2020 and $1.4 million during the three months ended March 31,
2021, primarily consisting of severance and related benefits. We expect an
additional $6 million to $8 million of cash payments to be made for fiscal year
2021 related to the Restructuring Plan.
Amounts reported in millions within this Quarterly Report on Form 10-Q are
computed based on the amounts in thousands. As a result, the sum of the
components reported in millions may not equal the total amount reported in
millions due to rounding. Certain columns and rows within the tables that follow
may not add due to the use of rounded numbers. Percentages presented are
calculated based on the respective amounts in thousands.
                                       23

--------------------------------------------------------------------------------

Table of Contents



Results of Operations
The following table sets forth, for the periods indicated, our unaudited results
of operations expressed as dollar amounts and as a percentage of total sales.
                                                                                   Three months ended March 31,
(dollars in thousands)                                         2021                % of Sales              2020              % of Sales
Sales
Product                                                  $      54,635                   71.6  %       $  56,525                   71.1  %
Service                                                         21,696                   28.4  %          22,990                   28.9  %
Total sales                                                     76,331                  100.0  %          79,515                  100.0  %
Cost of Sales
Product                                                         24,804                   32.5  %          23,066                   29.0  %
Service                                                         11,120                   14.6  %          12,576                   15.8  %
Total cost of sales                                             35,924                   47.1  %          35,642                   44.8  %
Gross Profit                                                    40,407                   52.9  %          43,873                   55.2  %
Operating Expenses
Selling, general and administrative                             33,348                   43.7  %          36,324                   45.7  %
Research and development                                        11,973                   15.7  %          10,415                   13.1  %
Restructuring costs                                              1,524                    2.0  %          13,688                   17.2  %
Total operating expenses                                        46,845                   61.4  %          60,427                   76.0  %
Loss from operations                                            (6,438)                  (8.4) %         (16,554)                 (20.8) %
Other (income) expense
Interest expense, net                                               10                      -  %              34                      -  %
Other (income) expense, net                                     (1,615)                  (2.1) %             473                    0.6  %
Loss before income tax benefit                                  (4,833)                  (6.3) %         (17,061)                 (21.5) %
Income tax benefit                                              (1,612)                  (2.1) %          (2,238)                  (2.8) %
Net loss                                                 $      (3,221)                  (4.2) %       $ (14,823)                 (18.6) %



Consolidated Results
Three Months Ended March 31, 2021 Compared to the Three Months Ended March 31,
2020
Sales. Total sales decreased by $3.2 million, or 4.0%, to $76.3 million for the
three months ended March 31, 2021 from $79.5 million for the three months ended
March 31, 2020. The decline in sales is the result of the economic effect of
COVID-19 pandemic, which is still in the recovery stage. Total product sales
decreased by $1.9 million, or 3.3%, to $54.6 million for the three months ended
March 31, 2021 from $56.5 million for the three months ended March 31, 2020
primarily due to the continuing COVID-19 related market softness and other
fluctuations in market conditions. Similarly, service revenue decreased by $1.3
million, or 5.6%, to $21.7 million for the three months ended March 31, 2021
from $23.0 million for the three months ended March 31, 2020. Foreign exchange
rates had a positive impact on total sales of $2.3 million, decreasing the
percent that our overall sales declined by approximately 2.9 percentage points,
primarily due to the strengthening of the Euro relative to the U.S. dollar.
Gross profit. Gross profit decreased by $3.5 million, or 7.9%, to $40.4 million
for the three months ended March 31, 2021 from $43.9 million for the three
months ended March 31, 2020, and gross margin decreased to 52.9% for the three
months ended March 31, 2021 from 55.2% for the three months ended March 31,
2020. Gross margin from product revenue decreased by 4.6 percentage points to
54.6% for the three months ended March 31, 2021 from 59.2% for the prior year
period primarily due to changes in product mix, an increased charge to our
reserve for excess and obsolete inventory, and the unfavorable impact of end
market demand softness related to the COVID-19 pandemic which adversely affected
our product fixed cost absorption. Gross margin from service revenue increased
by 3.4 percentage points to 48.7% for the three months ended March 31, 2021 from
45.3% for the prior year period, primarily due to a reduction in departmental
costs as a result of the Restructuring Plan.
                                       24
--------------------------------------------------------------------------------
  Table of Contents
Selling, general and administrative expenses. Selling, general and
administrative expenses decreased by $3.0 million, or 8.2%, to $33.3 million for
the three months ended March 31, 2021 from $36.3 million for the three months
ended March 31, 2020. This decrease was driven primarily by decreased salaries
and wages and other cost savings initiatives to reduce non-personnel costs that
resulted from the Restructuring Plan. Selling, general and administrative
expenses as a percentage of sales decreased to 43.7% for the three months ended
March 31, 2021, compared with 45.7% of sales for the three months ended March
31, 2020. Our worldwide period-ending selling, general and administrative
headcount decreased by 134, or 15.6%, to 727 at March 31, 2021, from 861 at
March 31, 2020.
Research and development expenses. Research and development expenses increased
by $1.6 million, or 15.0%, to $12.0 million for the three months ended March 31,
2021 from $10.4 million for the three months ended March 31, 2020. This increase
was mainly driven by higher compensation expense resulting from increased
engineering headcount and costs to accelerate new product development. Research
and development expenses as a percentage of sales increased to 15.7% for the
three months ended March 31, 2021 from 13.1% for the three months ended March
31, 2020.
Restructuring costs. In February 2020, we initiated the Restructuring Plan to
improve business effectiveness, streamline operations and achieve a stated
target cost level for the Company as a whole. Restructuring costs included in
operating expenses for the three months ended March 31, 2021 and March 31, 2020
were $1.5 million and $13.7 million, respectively, primarily consisting of
severance and related benefits charges.
Interest expense, net. We recorded interest expense, net of less than $0.1
million for the three months ended March 31, 2021 and three months ended March
31, 2020.
Other (income) expense, net. For the three months ended March 31, 2021, other
income was $1.6 million compared with other expense of $0.5 million for the
three months ended March 31, 2020. This change was primarily driven by the
effect of foreign exchange rates as well as COVID-19 related foreign incentives
received in the current year quarter.
Income tax benefit. For the three months ended March 31, 2021, we recorded an
income tax benefit of $1.6 million compared with income tax benefit of $2.2
million for the three months ended March 31, 2020. Our effective tax rate was
33.4% for the three months ended March 31, 2021 compared with 13.1% in the prior
year period. The change in our income benefit was primarily due to a lower
pretax loss during the first quarter of 2021 and changes in our effective tax
rate. The change in our effective tax rate was primarily associated with
discrete tax items, including excess tax benefits associated with the Company's
stock-based compensation arrangements, and a shift in the geographic mix of
pretax income expected for the full year 2021.
Our quarterly estimate of our annual effective tax rate and our quarterly
provision for income tax (benefit) expense are subject to significant variation
due to numerous factors, including variability in accurately predicting our
pretax and taxable income or loss and the mix of jurisdictions to which they
relate, as well as the amount of pretax income or loss recognized during the
quarter.
Net loss. Our net loss was $3.2 million for the three months ended March 31,
2021 compared with net loss of $14.8 million for the prior year period,
reflecting the impact of the factors described above.
                                       25
--------------------------------------------------------------------------------
  Table of Contents
Liquidity and Capital Resources
Cash and cash equivalents decreased by $15.6 million to $170.0 million at March
31, 2021 from $185.6 million at December 31, 2020. The decrease was primarily
driven by net cash used in operating and investing activities. Cash used in
operating activities was $10.3 million during the three months ended March 31,
2021, compared to $16.3 million of cash provided by operations during the three
months ended March 31, 2020. The decrease was mainly due to changes in working
capital accounts, primarily a decrease in accrued liabilities driven by the
$12.3 million settlement of liability related to the GSA matter.
Cash used in investing activities during the three months ended March 31, 2021
was $2.4 million compared to cash provided by investing activities of $7.8
million during the three months ended March 31, 2020. The change was primarily
due to the maturity of U.S. Treasury Bills amounting to $9.0 million during the
three months ended March 31, 2020 without such activity during the three months
ended March 31, 2021.
Cash provided by financing activities was $1.7 million during the three months
ended March 31, 2021 compared to cash provided by financing activities of $1.1
million for the three months ended March 31, 2020. The change was primarily due
to $5.1 million in cash received from the exercise of employee stock options
during the three months ended March 31, 2021 compared to $2.8 million during the
three months ended March 31, 2020.
Of our cash and cash equivalents, $120.5 million was held by foreign
subsidiaries as of March 31, 2021. On December 22, 2017, the United States
enacted the U.S. Tax Cuts and Jobs Act, resulting in significant modifications
to existing tax law, which included a transition tax on the mandatory deemed
repatriation of foreign earnings. As a result of the U.S. Tax Cuts and Jobs Act,
the Company can repatriate foreign earnings and profits to the U.S. with minimal
U.S. income tax consequences, other than the transition tax and global
intangible low-taxed income ("GILTI") tax. The Company has reinvested a large
portion of its undistributed foreign earnings and profits in acquisitions and
other investments and intends to bring back a portion of foreign cash in certain
jurisdictions where the Company will not be subject to local withholding taxes
and which were subject already to transition tax and GILTI tax.
On November 24, 2008, our Board of Directors approved a $30.0 million share
repurchase program. Acquisitions for the share repurchase program may be made
from time to time at prevailing prices, as permitted by securities laws and
other legal requirements, and subject to market conditions and other factors.
The share repurchase program may be discontinued at any time. There is no
expiration date or other restriction governing the period over which we can
repurchase shares under the program. In October 2015, our Board of Directors
authorized an increase to the existing share repurchase program from $30.0
million to $50.0 million. We made no stock repurchases during the three month
period ended March 31, 2021 under this program. As of March 31, 2021, we had
authorization to repurchase $18.3 million remaining under the repurchase
program.
We believe that our working capital and anticipated cash flow from operations
will be sufficient to fund our long-term liquidity operating requirements for at
least the next 12 months.
We have no off-balance sheet arrangements.
Contractual Obligations and Commercial Commitments
We enter into purchase commitments for products and services in the ordinary
course of business. These purchases generally cover production requirements for
60 to 120 days as well as materials necessary to service customer units through
the product lifecycle and for warranty commitments. As of March 31, 2021, we had
$42.0 million in purchase commitments that are expected to be delivered within
the next 12 months. Other than as described in the preceding sentences, there
have been no material changes to the contractual obligations and commercial
commitments table included in Part II, Item 7 of our Annual Report on Form 10-K
for the year ended December 31, 2020.
Critical Accounting Policies
The preparation of our condensed consolidated financial statements requires our
management to make estimates and assumptions that affect the reported amounts of
assets, liabilities, revenues, and expenses, as well as disclosure of contingent
assets and liabilities. We base our estimates on historical experience, along
with various other factors believed to be reasonable under the circumstances,
the results of which form the basis for making judgments about the carrying
value of assets and liabilities that are not readily apparent from other
sources. Some of these judgments can be subjective and complex and,
consequently, actual results may differ from these estimates under different
assumptions or conditions. A discussion of our critical accounting policies is
included in Part II, Item 7, "Management's Discussion and Analysis of Financial
Condition and Results of Operations" in our Annual Report on Form 10-K for the
year ended December 31, 2020, as filed with the Securities and Exchange
Commission on February 19, 2020. As of March 31, 2021, our critical accounting
policies have not changed from those described in our Annual Report on Form 10-K
for the year ended December 31, 2020.
                                       26

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses